aluates Reports

$ 0.0

Automative

Global Enzalutamide Tablets Market Research Report 2026

Published Date: 2026-01-29

Report Code: QYRE-Auto-27D18142

Global Enzalutamide Tablets Market Research Report 2024

BUY CHAPTERS

Global Enzalutamide Tablets Market Research Report 2026

Code: QYRE-Auto-27D18142

Report

2026-01-29

Pages:101

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Aurisco

Astellas/Pfizer

Enzalutamide Tablets Market

The global Enzalutamide Tablets market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Enzalutamide Tablets competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Enzalutamide is an active pharmaceutical ingredient (API) used primarily in the treatment of prostate cancer. It is an androgen receptor inhibitor that works by blocking the action of androgens (male hormones like testosterone) on cancer cells, which can help slow the growth and spread of tumors.

The North American market for Enzalutamide Tablets is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Enzalutamide Tablets is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of Enzalutamide Tablets include Astellas/Pfizer, AURISCO, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Enzalutamide Tablets market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Enzalutamide Tablets. The Enzalutamide Tablets market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Enzalutamide Tablets market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Enzalutamide Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Enzalutamide Tablets Market Report

Report Metric	Details
Report Name	Enzalutamide Tablets Market
Segment by Type	40mg 80mg
by Application	Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Castration- Resistant Prostate Cancer (NM-CRPC)
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Astellas/Pfizer, AURISCO
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Enzalutamide Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Enzalutamide Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Enzalutamide Tablets Market report?

Ans: The main players in the Enzalutamide Tablets Market are Astellas/Pfizer, AURISCO

What are the Application segmentation covered in the Enzalutamide Tablets Market report?

Ans: The Applications covered in the Enzalutamide Tablets Market report are Metastatic Hormone-Sensitive Prostate Cancer (mHSPC), Castration- Resistant Prostate Cancer (NM-CRPC)

What are the Type segmentation covered in the Enzalutamide Tablets Market report?

Ans: The Types covered in the Enzalutamide Tablets Market report are 40mg, 80mg

1 Enzalutamide Tablets Market Overview

1.1 Product Definition

1.2 Enzalutamide Tablets by Type

1.2.1 Global Enzalutamide Tablets Market Value by Type: 2025 vs 2032

1.2.2 40mg

1.2.3 80mg

1.3 Enzalutamide Tablets by Application

1.3.1 Global Enzalutamide Tablets Market Value by Application: 2025 vs 2032

1.3.2 Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

1.3.3 Castration- Resistant Prostate Cancer (NM-CRPC)

1.4 Global Enzalutamide Tablets Market Size Estimates and Forecasts

1.4.1 Global Enzalutamide Tablets Revenue 2021–2032

1.4.2 Global Enzalutamide Tablets Sales 2021–2032

1.4.3 Global Enzalutamide Tablets Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 Enzalutamide Tablets Market Competition by Manufacturers

2.1 Global Enzalutamide Tablets Sales Market Share by Manufacturers (2021–2026)

2.2 Global Enzalutamide Tablets Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Enzalutamide Tablets Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Enzalutamide Tablets, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Enzalutamide Tablets, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Enzalutamide Tablets, Product Types and Applications

2.7 Global Key Manufacturers of Enzalutamide Tablets, Date of Entry into the Industry

2.8 Global Enzalutamide Tablets Market Competitive Situation and Trends

2.8.1 Global Enzalutamide Tablets Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Enzalutamide Tablets Players Market Share by Revenue

2.8.3 Global Enzalutamide Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Enzalutamide Tablets Market Scenario by Region

3.1 Global Enzalutamide Tablets Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Enzalutamide Tablets Sales by Region: 2021–2032

3.2.1 Global Enzalutamide Tablets Sales by Region: 2021–2026

3.2.2 Global Enzalutamide Tablets Sales by Region: 2027–2032

3.3 Global Enzalutamide Tablets Revenue by Region: 2021–2032

3.3.1 Global Enzalutamide Tablets Revenue by Region: 2021–2026

3.3.2 Global Enzalutamide Tablets Revenue by Region: 2027–2032

3.4 North America Enzalutamide Tablets Market Facts & Figures by Country

3.4.1 North America Enzalutamide Tablets Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Enzalutamide Tablets Sales by Country (2021–2032)

3.4.3 North America Enzalutamide Tablets Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Enzalutamide Tablets Market Facts & Figures by Country

3.5.1 Europe Enzalutamide Tablets Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Enzalutamide Tablets Sales by Country (2021–2032)

3.5.3 Europe Enzalutamide Tablets Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Enzalutamide Tablets Market Facts & Figures by Region

3.6.1 Asia Pacific Enzalutamide Tablets Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Enzalutamide Tablets Sales by Region (2021–2032)

3.6.3 Asia Pacific Enzalutamide Tablets Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Enzalutamide Tablets Market Facts & Figures by Country

3.7.1 Latin America Enzalutamide Tablets Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Enzalutamide Tablets Sales by Country (2021–2032)

3.7.3 Latin America Enzalutamide Tablets Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Enzalutamide Tablets Market Facts & Figures by Country

3.8.1 Middle East and Africa Enzalutamide Tablets Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Enzalutamide Tablets Sales by Country (2021–2032)

3.8.3 Middle East and Africa Enzalutamide Tablets Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Enzalutamide Tablets Sales by Type (2021–2032)

4.1.1 Global Enzalutamide Tablets Sales by Type (2021–2026)

4.1.2 Global Enzalutamide Tablets Sales by Type (2027–2032)

4.1.3 Global Enzalutamide Tablets Sales Market Share by Type (2021–2032)

4.2 Global Enzalutamide Tablets Revenue by Type (2021–2032)

4.2.1 Global Enzalutamide Tablets Revenue by Type (2021–2026)

4.2.2 Global Enzalutamide Tablets Revenue by Type (2027–2032)

4.2.3 Global Enzalutamide Tablets Revenue Market Share by Type (2021–2032)

4.3 Global Enzalutamide Tablets Price by Type (2021–2032)

5 Segment by Application

5.1 Global Enzalutamide Tablets Sales by Application (2021–2032)

5.1.1 Global Enzalutamide Tablets Sales by Application (2021–2026)

5.1.2 Global Enzalutamide Tablets Sales by Application (2027–2032)

5.1.3 Global Enzalutamide Tablets Sales Market Share by Application (2021–2032)

5.2 Global Enzalutamide Tablets Revenue by Application (2021–2032)

5.2.1 Global Enzalutamide Tablets Revenue by Application (2021–2026)

5.2.2 Global Enzalutamide Tablets Revenue by Application (2027–2032)

5.2.3 Global Enzalutamide Tablets Revenue Market Share by Application (2021–2032)

5.3 Global Enzalutamide Tablets Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Astellas/Pfizer

6.1.1 Astellas/Pfizer Company Information

6.1.2 Astellas/Pfizer Description and Business Overview

6.1.3 Astellas/Pfizer Enzalutamide Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Astellas/Pfizer Enzalutamide Tablets Product Portfolio

6.1.5 Astellas/Pfizer Recent Developments/Updates

6.2 AURISCO

6.2.1 AURISCO Company Information

6.2.2 AURISCO Description and Business Overview

6.2.3 AURISCO Enzalutamide Tablets Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 AURISCO Enzalutamide Tablets Product Portfolio

6.2.5 AURISCO Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Enzalutamide Tablets Industry Chain Analysis

7.2 Enzalutamide Tablets Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Enzalutamide Tablets Production Mode & Process Analysis

7.4 Enzalutamide Tablets Sales and Marketing

7.4.1 Enzalutamide Tablets Sales Channels

7.4.2 Enzalutamide Tablets Distributors

7.5 Enzalutamide Tablets Customer Analysis

8 Enzalutamide Tablets Market Dynamics

8.1 Enzalutamide Tablets Industry Trends

8.2 Enzalutamide Tablets Market Drivers

8.3 Enzalutamide Tablets Market Challenges

8.4 Enzalutamide Tablets Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Aurisco

Astellas/Pfizer

List of Tables

Table 1. Global Enzalutamide Tablets Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Enzalutamide Tablets Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Enzalutamide Tablets Market Competitive Situation by Manufacturers in 2025

Table 4. Global Enzalutamide Tablets Sales (K Units) of Key Manufacturers (2021–2026)

Table 5. Global Enzalutamide Tablets Sales Market Share by Manufacturers (2021–2026)

Table 6. Global Enzalutamide Tablets Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global Enzalutamide Tablets Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market Enzalutamide Tablets Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of Enzalutamide Tablets, Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of Enzalutamide Tablets, Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of Enzalutamide Tablets, Product Types and Applications

Table 12. Global Key Manufacturers of Enzalutamide Tablets, Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Enzalutamide Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Enzalutamide Tablets Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Enzalutamide Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Enzalutamide Tablets Sales by Region (K Units), 2021–2026

Table 18. Global Enzalutamide Tablets Sales Market Share by Region (2021–2026)

Table 19. Global Enzalutamide Tablets Sales by Region (K Units), 2027–2032

Table 20. Global Enzalutamide Tablets Sales Market Share by Region (2027–2032)

Table 21. Global Enzalutamide Tablets Revenue by Region (US$ Million), 2021–2026

Table 22. Global Enzalutamide Tablets Revenue Market Share by Region (2021–2026)

Table 23. Global Enzalutamide Tablets Revenue by Region (US$ Million), 2027–2032

Table 24. Global Enzalutamide Tablets Revenue Market Share by Region (2027–2032)

Table 25. North America Enzalutamide Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America Enzalutamide Tablets Sales by Country (K Units), 2021–2026

Table 27. North America Enzalutamide Tablets Sales by Country (K Units), 2027–2032

Table 28. North America Enzalutamide Tablets Revenue by Country (US$ Million), 2021–2026

Table 29. North America Enzalutamide Tablets Revenue by Country (US$ Million), 2027–2032

Table 30. Europe Enzalutamide Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe Enzalutamide Tablets Sales by Country (K Units), 2021–2026

Table 32. Europe Enzalutamide Tablets Sales by Country (K Units), 2027–2032

Table 33. Europe Enzalutamide Tablets Revenue by Country (US$ Million), 2021–2026

Table 34. Europe Enzalutamide Tablets Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific Enzalutamide Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific Enzalutamide Tablets Sales by Region (K Units), 2021–2026

Table 37. Asia Pacific Enzalutamide Tablets Sales by Region (K Units), 2027–2032

Table 38. Asia Pacific Enzalutamide Tablets Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific Enzalutamide Tablets Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America Enzalutamide Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America Enzalutamide Tablets Sales by Country (K Units), 2021–2026

Table 42. Latin America Enzalutamide Tablets Sales by Country (K Units), 2027–2032

Table 43. Latin America Enzalutamide Tablets Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America Enzalutamide Tablets Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa Enzalutamide Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa Enzalutamide Tablets Sales by Country (K Units), 2021–2026

Table 47. Middle East and Africa Enzalutamide Tablets Sales by Country (K Units), 2027–2032

Table 48. Middle East and Africa Enzalutamide Tablets Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa Enzalutamide Tablets Revenue by Country (US$ Million), 2027–2032

Table 50. Global Enzalutamide Tablets Sales (K Units) by Type (2021–2026)

Table 51. Global Enzalutamide Tablets Sales (K Units) by Type (2027–2032)

Table 52. Global Enzalutamide Tablets Sales Market Share by Type (2021–2026)

Table 53. Global Enzalutamide Tablets Sales Market Share by Type (2027–2032)

Table 54. Global Enzalutamide Tablets Revenue (US$ Million) by Type (2021–2026)

Table 55. Global Enzalutamide Tablets Revenue (US$ Million) by Type (2027–2032)

Table 56. Global Enzalutamide Tablets Revenue Market Share by Type (2021–2026)

Table 57. Global Enzalutamide Tablets Revenue Market Share by Type (2027–2032)

Table 58. Global Enzalutamide Tablets Price (US$/Unit) by Type (2021–2026)

Table 59. Global Enzalutamide Tablets Price (US$/Unit) by Type (2027–2032)

Table 60. Global Enzalutamide Tablets Sales (K Units) by Application (2021–2026)

Table 61. Global Enzalutamide Tablets Sales (K Units) by Application (2027–2032)

Table 62. Global Enzalutamide Tablets Sales Market Share by Application (2021–2026)

Table 63. Global Enzalutamide Tablets Sales Market Share by Application (2027–2032)

Table 64. Global Enzalutamide Tablets Revenue (US$ Million) by Application (2021–2026)

Table 65. Global Enzalutamide Tablets Revenue (US$ Million) by Application (2027–2032)

Table 66. Global Enzalutamide Tablets Revenue Market Share by Application (2021–2026)

Table 67. Global Enzalutamide Tablets Revenue Market Share by Application (2027–2032)

Table 68. Global Enzalutamide Tablets Price (US$/Unit) by Application (2021–2026)

Table 69. Global Enzalutamide Tablets Price (US$/Unit) by Application (2027–2032)

Table 70. Astellas/Pfizer Company Information

Table 71. Astellas/Pfizer Description and Business Overview

Table 72. Astellas/Pfizer Enzalutamide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 73. Astellas/Pfizer Enzalutamide Tablets Product

Table 74. Astellas/Pfizer Recent Developments/Updates

Table 75. AURISCO Company Information

Table 76. AURISCO Description and Business Overview

Table 77. AURISCO Enzalutamide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 78. AURISCO Enzalutamide Tablets Product

Table 79. AURISCO Recent Developments/Updates

Table 80. Key Raw Materials Lists

Table 81. Raw Materials Key Suppliers Lists

Table 82. Enzalutamide Tablets Distributors List

Table 83. Enzalutamide Tablets Customers List

Table 84. Enzalutamide Tablets Market Trends

Table 85. Enzalutamide Tablets Market Drivers

Table 86. Enzalutamide Tablets Market Challenges

Table 87. Enzalutamide Tablets Market Restraints

Table 88. Research Programs/Design for This Report

Table 89. Key Data Information from Secondary Sources

Table 90. Key Data Information from Primary Sources

Table 91. Authors List of This Report

List of Figures

Figure 1. Product Picture of Enzalutamide Tablets

Figure 2. Global Enzalutamide Tablets Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Enzalutamide Tablets Market Share by Type: 2025 & 2032

Figure 4. 40mg Product Picture

Figure 5. 80mg Product Picture

Figure 6. Global Enzalutamide Tablets Market Value by Application (US$ Million), 2021–2032

Figure 7. Global Enzalutamide Tablets Market Share by Application: 2025 & 2032

Figure 8. Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Figure 9. Castration- Resistant Prostate Cancer (NM-CRPC)

Figure 10. Global Enzalutamide Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 11. Global Enzalutamide Tablets Market Size (US$ Million), 2021–2032

Figure 12. Global Enzalutamide Tablets Sales (K Units), 2021–2032

Figure 13. Global Enzalutamide Tablets Average Price (US$/Unit), 2021–2032

Figure 14. Enzalutamide Tablets Report Years Considered

Figure 15. Enzalutamide Tablets Sales Share by Manufacturers in 2025

Figure 16. Global Enzalutamide Tablets Revenue Share by Manufacturers in 2025

Figure 17. Top 5 and Top 10 Global Enzalutamide Tablets Players: Market Share by Revenue in Enzalutamide Tablets in 2025

Figure 18. Enzalutamide Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 19. Global Enzalutamide Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 20. North America Enzalutamide Tablets Sales Market Share by Country (2021–2032)

Figure 21. North America Enzalutamide Tablets Revenue Market Share by Country (2021–2032)

Figure 22. United States Enzalutamide Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 23. Canada Enzalutamide Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 24. Europe Enzalutamide Tablets Sales Market Share by Country (2021–2032)

Figure 25. Europe Enzalutamide Tablets Revenue Market Share by Country (2021–2032)

Figure 26. Germany Enzalutamide Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 27. France Enzalutamide Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 28. U.K. Enzalutamide Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 29. Italy Enzalutamide Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. Russia Enzalutamide Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. Asia Pacific Enzalutamide Tablets Sales Market Share by Region (2021–2032)

Figure 32. Asia Pacific Enzalutamide Tablets Revenue Market Share by Region (2021–2032)

Figure 33. China Enzalutamide Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. Japan Enzalutamide Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. South Korea Enzalutamide Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. India Enzalutamide Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. Australia Enzalutamide Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. China Taiwan Enzalutamide Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. Southeast Asia Enzalutamide Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Latin America Enzalutamide Tablets Sales Market Share by Country (2021–2032)

Figure 41. Latin America Enzalutamide Tablets Revenue Market Share by Country (2021–2032)

Figure 42. Mexico Enzalutamide Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Brazil Enzalutamide Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. Argentina Enzalutamide Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Colombia Enzalutamide Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Middle East and Africa Enzalutamide Tablets Sales Market Share by Country (2021–2032)

Figure 47. Middle East and Africa Enzalutamide Tablets Revenue Market Share by Country (2021–2032)

Figure 48. Turkey Enzalutamide Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Saudi Arabia Enzalutamide Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. UAE Enzalutamide Tablets Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Global Sales Market Share of Enzalutamide Tablets by Type (2021–2032)

Figure 52. Global Revenue Market Share of Enzalutamide Tablets by Type (2021–2032)

Figure 53. Global Enzalutamide Tablets Price (US$/Unit) by Type (2021–2032)

Figure 54. Global Sales Market Share of Enzalutamide Tablets by Application (2021–2032)

Figure 55. Global Revenue Market Share of Enzalutamide Tablets by Application (2021–2032)

Figure 56. Global Enzalutamide Tablets Price (US$/Unit) by Application (2021–2032)

Figure 57. Enzalutamide Tablets Value Chain

Figure 58. Channels of Distribution (Direct Vs Distribution)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global Enzalutamide API Market

Global Oncology API Market Research Report 2024

Global Finasteride API Market Research Report 2024

Finasteride Oral Tablet Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anastrozole APl Market Research Report 2024

Global Finasteride Oral Route Market Research Report 2024

Global Ceritinib API Market Research Report 2024

Global Neratinib Maleate Tablets Market Research Report 2024

Global 5α Reductase Inhibitors Market Research Report 2025

Global Androgen Receptor AR Antagonist Market Research Report 2024

Global Afatinib API Market Research Report 2024

Global Enanton Leucorin Acetate Market Research Report 2024

Global Dutasteride API Market Research Report 2024

Global Sacubitril Valsartan API Market Research Report 2025

Global Bicalutamide Market Research Report 2024

Global Nilutamide Market Research Report 2024

Testosterone Blocker Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prostate Cancer Medicine Market Insights Forecast to 2030

Global Aromatase Inhibitors Market Research Report 2024

Relugolix API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions